Volume | 69,490 |
|
|||||
News | - | ||||||
Day High | 1.51 | Low High |
|||||
Day Low | 1.46 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
UNITY Biotechnology Inc | UBX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.50 | 1.46 | 1.51 | 1.49 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
402 | 69,490 | $ 1.48 | $ 102,743 | - | 1.46 - 3.82 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:30:32 | 200 | $ 1.4699 | USD |
UNITY Biotechnology Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
21.35M | 14.62M | - | 0 | -39.86M | -2.73 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
UNITY Biotechnology News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UBX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.52 | 1.54 | 1.46 | 1.49 | 42,004 | -0.0501 | -3.30% |
1 Month | 1.65 | 1.67 | 1.46 | 1.55 | 56,587 | -0.1801 | -10.92% |
3 Months | 1.68 | 2.02 | 1.46 | 1.68 | 92,466 | -0.2101 | -12.51% |
6 Months | 1.83 | 2.26 | 1.46 | 1.77 | 94,419 | -0.3601 | -19.68% |
1 Year | 2.32 | 3.82 | 1.46 | 2.35 | 118,108 | -0.8501 | -36.64% |
3 Years | 50.30 | 53.00 | 1.46 | 12.81 | 744,977 | -48.83 | -97.08% |
5 Years | 80.00 | 154.40 | 1.46 | 28.84 | 669,155 | -78.53 | -98.16% |
UNITY Biotechnology Description
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. |